WallStSmart
MGX

Metagenomi, Inc. Common Stock

NASDAQ: MGX · HEALTHCARE · BIOTECHNOLOGY

$1.38
+2.22% today

Updated 2026-04-30

Market cap
$55.68M
P/E ratio
P/S ratio
2.21x
EPS (TTM)
$-2.36
Dividend yield
52W range
$1 – $4
Volume
0.2M

Metagenomi, Inc. Common Stock (MGX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+38.4%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.5%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-13.5%
2025-11-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-01$0.00+100.0%$1.34$1.35+0.7%
2026-03-06$-0.60-2.6%$1.61$1.60-0.6%
2025-11-11$-0.55+31.3%$2.15$1.86-13.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.81$0.00+100.0%
2025-12-31$-0.59$-0.60-2.6%$3.91M-59.3%
2025-09-30$-0.80$-0.55+31.3%$8.66M-24.8%
2025-06-30$-0.72$-0.54+25.0%$8.51M-57.5%
2025-03-31$-0.75$-0.68+9.3%$4.13M-63.0%
2024-12-31$-0.77$-0.37+51.9%$9.61M-22.5%
2024-09-30$-0.75$-0.51+32.0%$11.51M
2024-06-30$-0.70$-0.29+58.6%$20.01M
2024-03-31$-0.78$-1.19-52.6%$11.16M
2023-12-31$-2.04$-0.51+74.8%$12.40M

Frequently asked questions

Has Metagenomi, Inc. Common Stock beaten earnings estimates?
Metagenomi, Inc. Common Stock has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +38.4% over the last 4 quarters.
How does MGX stock react to earnings?
MGX stock has moved an average of -4.5% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.